# Clinical Trial of YYC301 P3 for Treatment of Osteoarthritis of the Knee

> **NCT05362851** · PHASE3 · UNKNOWN · sponsor: **Yooyoung Pharmaceutical Co., Ltd.** · enrollment: 692 (estimated)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** YYC301-1 & YYC301-2 & YYC301-3
- **DRUG:** YYC301 placebo & Celecoxib 200mg

## Key facts

- **NCT ID:** NCT05362851
- **Lead sponsor:** Yooyoung Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-11
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 692 (ESTIMATED)
- **Last updated:** 2022-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05362851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05362851, "Clinical Trial of YYC301 P3 for Treatment of Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT05362851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*